Le Lézard
Classified in: Health
Subjects: PSF, CFG

Public Advisory - Fake Viagra seized from Jug City store in Scarborough, ON


OTTAWA, ON, April 26, 2024 /CNW/ -

Summary

Viagra (Back) (CNW Group/Health Canada (HC))

Viagra (Front) (CNW Group/Health Canada (HC))

Affected Products
Counterfeit Viagra, 100 mg sildenafil tablets

Issue
Health Canada has seized counterfeit Viagra from a Jug City store in Scarborough, Ontario (96 Dearham Wood). This is in addition to several other unauthorised sexual enhancement products seized from the same store.  

The counterfeit Viagra was sold in individual blister packs with no other packaging. Authorized Viagra is usually sold with an outer carton and a leaflet outlining the directions for use. Other indicators that the product is fake include an expiry date in an incorrect format ("EXP032 025") and no lot number printed on the blister pack.

Counterfeit drugs are made to look like authentic products, but they are not the same and they may not contain the drug at all. They can pose serious health risks if they contain a higher dosage than shown on the label, and could contain contaminants and hidden ingredients. Unlike authorized and authentic drug products, counterfeit drugs have not been assessed by Health Canada for safety, effectiveness, and quality. Selling counterfeit health products is illegal.

Health Canada has confirmed with the authorized manufacturer of Viagra that the seized product is counterfeit. Like authentic Viagra, the seized product is labelled to contain the prescription drug sildenafil. Sildenafil should be used only under the supervision of a health care professional. It should not be used by individuals taking any kind of nitrate drug (e.g., nitroglycerin) as it can cause potentially life-threatening low blood pressure. Individuals with heart problems are at increased risk of cardiovascular side effects such as heart attack, stroke, chest pain, high blood pressure, and abnormal heartbeat. Other possible side effects include headache, facial flushing, indigestion, dizziness, abnormal vision, and hearing loss.

Health Canada reminds consumers that the best way to make sure their prescription drugs are authentic is to buy them from a licensed pharmacy. Moreover, prescription drugs should be taken only under the advice and supervision of a health care professional because they are used to treat specific health conditions and may cause serious side effects. Prescription drugs can only be legally sold to consumers in Canada with a prescription and cannot be sold in convenience stores.

For more information regarding Health Canada's approach to counterfeit health products, please consult Health Canada's Policy on Counterfeit Health Products.

What you should do

Également disponible en français

SOURCE Health Canada (HC)


These press releases may also interest you

8 mai 2024
Tri-Tech Forensics, Inc. (Tri-Tech), a leading provider of tactical emergency medical solutions and human identification kits, is pleased to announce the acquisition of SAM® Medical (SAM Medical), a globally renowned provider of innovative medical...

8 mai 2024
The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.64 billion (USD 10.8 million1) in four projects for the development of new drugs for malaria and neglected tropical diseases (NTDs).2  The...

8 mai 2024
Renova Therapeutics, a biotechnology company developing gene therapy-based treatments for cardiovascular and metabolic diseases, announced today that it has focused its development and commercialization efforts for its RT-100 and RT-200 gene...

8 mai 2024
Organovo Holdings, Inc. ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches based on demonstration of clinical promise in three-dimensional (3D) human tissues, today announced the...

8 mai 2024
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology...

8 mai 2024
NCPDP announced today highlights from its 2024 Annual Technology & Business Conference, Innovation Starts Here. "NCPDP's standards and guidance are inherently innovative, and the work we continue to do will expand interoperability to support the...



News published on and distributed by: